IONQ
$31.27
+0.35% today · -0.03% 1W
Oct 23 close or latest
After hours $31.27 0.00% ·
Meta Analyst score Buy 6.8/10 (+0.79 raw)
Every firm's latest rating in the past year, each weighted by its age (a 3-month-old call counts half as much as today's), blended with the consensus of 14 analysts (+0.93, counted like 1.5 fresh ratings), and pulled toward the typical S&P 500 score (+0.64) as if that were 3 more fresh ratings, so a score from few or old calls says less. 10 firms, 8 with a call in the past 3 months.
| Firm | Latest rating | Date | Weight |
|---|---|---|---|
| Rosenblatt | Buy | Oct 15, 2026 | 8% |
| Morgan Stanley | Equal-Weight | Oct 15, 2026 | 8% |
| B of A Securities | Buy | Sep 28, 2026 | 7% |
| Wedbush | Outperform | Sep 22, 2026 | 7% |
| Cantor Fitzgerald | Overweight | Sep 9, 2026 | 6% |
| Needham | Buy | Sep 9, 2026 | 6% |
| Mizuho | Outperform | Sep 9, 2026 | 6% |
| Benchmark | Buy | Aug 6, 2026 | 5% |
| Northland Capital Markets | Outperform | Jun 22, 2026 | 3% |
| JP Morgan | Neutral | May 7, 2026 | 2% |
Buy is what the ratings average to, +0.79 on a scale from −2 (strong sell) to +2 (strong buy). 6.8/10 means better than 68% of S&P 500 stocks (503 scored, Oct 18, 2026): analysts rarely say sell, so most stocks land between +0.4 and +0.8, and the 0–10 shows where this one sits among them.
Mean target
$64.06
+104.9% upside
Median target
$62.50
+99.9% upside
Target range
41.85–100.00
low to high
Analysts
14
as of Oct 24
Price vs. targets
Low $42
Mean $64
High $100
Now $31.27
Consensus
Strong buy 1Buy 11Hold 2Sell 0Strong sell 0
Rating and target changes
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| Oct 15, 2026 | Rosenblatt | Lowered target | Buy | $100.00 → $70.00 |
| Oct 15, 2026 | Morgan Stanley | Lowered target | Equal-Weight | $49.00 → $43.00 |
| Oct 13, 2026 | Rosenblatt | Reiterated | Buy | $100.00 |
| Sep 28, 2026 | B of A Securities | Initiated | Buy | $60.00 |
| Sep 22, 2026 | Wedbush | Reiterated | Outperform | $75.00 |
| Sep 9, 2026 | Cantor Fitzgerald | Reiterated | Overweight | $70.00 |
| Sep 9, 2026 | Needham | Reiterated | Buy | $65.00 |
| Sep 9, 2026 | Rosenblatt | Reiterated | Buy | $100.00 |
| Sep 9, 2026 | Mizuho | Lowered target | Outperform | $61.00 → $52.00 |
| Aug 6, 2026 | Rosenblatt | Reiterated | Buy | $100.00 |
| Aug 6, 2026 | Cantor Fitzgerald | Reiterated | Overweight | $70.00 |
| Aug 6, 2026 | Needham | Reiterated | Buy | $65.00 |
| Aug 6, 2026 | Benchmark | Reiterated | Buy | $60.00 |
| Jun 22, 2026 | Northland Capital Markets | Raised target | Outperform | $55.00 → $70.00 |
| Jun 11, 2026 | Rosenblatt | Reiterated | Buy | $100.00 |
| May 7, 2026 | Wedbush | Raised target | Outperform | $60.00 → $75.00 |
| May 7, 2026 | JP Morgan | Raised target | Neutral | $42.00 → $50.00 |
| May 4, 2026 | Wedbush | Reiterated | Outperform | $60.00 |
| Apr 20, 2026 | Northland Capital Markets | Initiated | Outperform | $55.00 |
Source: Yahoo Finance analyst data, collected daily.